Double maintains 3 strategies that include CRSP - CRISPR Therapeutics AG
Current Value
$37.301 Year Return
Current Value
$37.301 Year Return
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
NEE | 0.08% | $153.47B | -2.43% | 2.84% |
CL | 0.10% | $72.64B | -5.18% | 2.25% |
KDP | -0.15% | $45.55B | -1.76% | 2.70% |
PRA | 0.16% | $1.19B | +58.17% | 0.00% |
COR | 0.23% | $55.43B | +28.90% | 0.56% |
CAG | 0.29% | $10.87B | -26.52% | 6.17% |
FDP | -0.31% | $1.57B | +33.46% | 4.14% |
MSIF | -0.40% | $715.25M | +28.42% | 7.05% |
PG | 0.58% | $380.78B | -3.25% | 2.51% |
CARV | -0.62% | $7.41M | -22.87% | 0.00% |
BTI | 0.65% | $90.76B | +31.13% | 7.29% |
ERIE | 0.72% | $17.14B | -7.12% | 1.44% |
ADC | 0.72% | $8.13B | +22.47% | 4.08% |
IMNN | 0.74% | $8.21M | -59.89% | 0.00% |
VSTA | 0.75% | $326.82M | +11.64% | 0.00% |
CCEC | 0.78% | $1.02B | +3.91% | 2.71% |
CB | 0.78% | $117.03B | +10.26% | 1.25% |
CALM | -0.78% | $5.17B | +66.43% | 6.96% |
BULL | -0.83% | $5.67B | +11.22% | 0.00% |
LMT | 0.89% | $108.98B | +0.07% | 2.79% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
ARKG | 79.29% | $944.78M | 0.75% |
GNOM | 73.88% | $40.65M | 0.5% |
XBI | 66.40% | $4.85B | 0.35% |
ARKK | 63.76% | $5.95B | 0.75% |
IBB | 61.08% | $5.22B | 0.45% |
PBE | 58.23% | $214.12M | 0.58% |
IWC | 57.56% | $766.88M | 0.6% |
IWO | 57.16% | $11.36B | 0.24% |
KOMP | 56.32% | $2.20B | 0.2% |
CPRJ | 55.80% | $48.43M | 0.69% |
QQQJ | 55.36% | $610.08M | 0.15% |
VBK | 55.20% | $18.33B | 0.07% |
IWM | 55.04% | $63.95B | 0.19% |
VTWO | 55.03% | $12.07B | 0.07% |
IBUY | 54.66% | $153.59M | 0.65% |
ISCG | 54.59% | $645.00M | 0.06% |
PBW | 54.58% | $269.08M | 0.65% |
FBT | 54.47% | $994.71M | 0.56% |
PTH | 54.20% | $96.56M | 0.6% |
SCHA | 54.14% | $16.91B | 0.04% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
RXRX | 72.72% | $1.73B | -55.31% | 0.00% |
BEAM | 71.12% | $1.73B | -27.49% | 0.00% |
NTLA | 69.62% | $836.43M | -69.14% | 0.00% |
ABCL | 62.24% | $602.94M | -46.56% | 0.00% |
ALLO | 59.62% | $238.42M | -63.79% | 0.00% |
TWST | 55.67% | $1.80B | -35.27% | 0.00% |
DNLI | 54.62% | $2.06B | -30.04% | 0.00% |
SDGR | 54.41% | $1.71B | +2.01% | 0.00% |
CRBU | 54.29% | $78.11M | -76.60% | 0.00% |
SITE | 54.21% | $5.50B | -19.85% | 0.00% |
FATE | 53.46% | $115.78M | -75.60% | 0.00% |
RCKT | 53.30% | $724.54M | -71.26% | 0.00% |
KYMR | 52.85% | $1.95B | -15.67% | 0.00% |
IMNM | 52.00% | $696.10M | -44.44% | 0.00% |
EYPT | 51.31% | $393.60M | -54.31% | 0.00% |
ACLX | 50.86% | $3.22B | +10.72% | 0.00% |
COHU | 50.51% | $829.14M | -40.03% | 0.00% |
EDIT | 50.02% | $116.78M | -76.32% | 0.00% |
TXG | 49.99% | $1.15B | -64.05% | 0.00% |
SYRE | 49.81% | $877.54M | -61.53% | 0.00% |
SeekingAlpha
Intellia Therapeutics reported further progress with two treatments that are now ensconced in Phase III of testing. Click here to see why NTLA stock is a Buy.
SeekingAlpha
CRISPR Therapeutics benefits from Casgevyâs approval and a deep pipeline, despite early rollout hurdles and cost challenges. Learn why CRSP stock is a buy.
SeekingAlpha
Read here for ARK Invest's latest 13F updates: portfolio value shifts, top holdings, significant trades, and their open-source investment research approach.
SeekingAlpha
CRISPR Therapeutics faces challenges with a 20% stock drop, slow Casgevy commercialization, and regulatory hurdles. Read more on why CRSP is a Sell.
SeekingAlpha
Crispr Therapeutics AG shows promise with innovative gene therapies like CTX-310, strong cash reserves, and a bullish long-term outlook. Click for my CRSP update.
Finnhub
Initial CTX310™ Phase 1 clinical data demonstrates dose-dependent decreases in triglycerides and low-density lipoprotein , with peak reduction of up to 82% in TG and up to 81% in LDL, with a...
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
CBOE | -19.89% | $22.95B | +20.67% | 1.12% |
MO | -14.61% | $97.80B | +26.35% | 6.94% |
ED | -14.06% | $36.75B | +5.26% | 3.28% |
VHC | -11.79% | $34.69M | +74.89% | 0.00% |
DUK | -11.67% | $90.12B | +12.74% | 3.61% |
T | -11.58% | $196.66B | +57.98% | 4.07% |
CME | -11.14% | $98.74B | +28.80% | 3.84% |
EXC | -9.91% | $43.84B | +12.45% | 3.59% |
FMTO | -8.15% | $45.74M | -99.96% | 0.00% |
BTCT | -8.09% | $25.35M | +93.08% | 0.00% |
LITB | -7.81% | $21.28M | -72.45% | 0.00% |
STG | -7.68% | $27.05M | -37.35% | 0.00% |
PSQH | -7.57% | $89.26M | -49.87% | 0.00% |
K | -6.84% | $28.49B | +32.17% | 2.77% |
ZCMD | -6.13% | $32.45M | -11.38% | 0.00% |
PGR | -5.16% | $164.82B | +35.81% | 1.74% |
AEP | -4.63% | $54.28B | +9.80% | 3.61% |
AWK | -4.50% | $27.37B | +4.54% | 2.22% |
NOC | -4.48% | $67.51B | -0.35% | 1.76% |
PM | -4.28% | $263.27B | +68.03% | 3.17% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
BSMR | 0.04% | $245.57M | 0.18% |
UTEN | -0.14% | $192.72M | 0.15% |
BIL | -0.16% | $45.95B | 0.1356% |
USL | 0.34% | $41.76M | 0.85% |
TDTF | -0.34% | $788.24M | 0.18% |
BNO | -0.37% | $86.13M | 1% |
OILK | 0.43% | $63.21M | 0.69% |
USO | -0.45% | $956.18M | 0.6% |
DBE | -0.60% | $48.48M | 0.77% |
JMST | -0.61% | $3.65B | 0.18% |
IBTO | -0.66% | $330.69M | 0.07% |
SHYD | 0.67% | $318.05M | 0.35% |
IEF | -0.69% | $34.17B | 0.15% |
TIPX | 0.82% | $1.64B | 0.15% |
GOVT | -0.86% | $27.25B | 0.05% |
TFLO | -0.92% | $7.06B | 0.15% |
YEAR | -0.93% | $1.40B | 0.25% |
GVI | 0.98% | $3.37B | 0.2% |
JPLD | 1.05% | $1.19B | 0.24% |
SMB | -1.17% | $269.10M | 0.07% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
BTAL | -50.18% | $361.41M | 1.43% |
VIXY | -36.49% | $109.64M | 0.85% |
TAIL | -34.54% | $140.49M | 0.59% |
IVOL | -21.99% | $353.94M | 1.02% |
FTSD | -16.52% | $212.46M | 0.25% |
LDUR | -14.74% | $849.09M | 0.5% |
CTA | -13.24% | $1.05B | 0.76% |
SPTS | -13.09% | $5.76B | 0.03% |
SHYM | -12.56% | $322.93M | 0.35% |
ULST | -12.06% | $637.77M | 0.2% |
STPZ | -11.77% | $446.46M | 0.2% |
UTWO | -10.02% | $387.71M | 0.15% |
SCHO | -9.93% | $10.87B | 0.03% |
IBTG | -9.50% | $1.88B | 0.07% |
FXY | -9.43% | $838.61M | 0.4% |
XONE | -9.31% | $603.24M | 0.03% |
VGSH | -9.05% | $22.38B | 0.03% |
CLIP | -8.25% | $1.50B | 0.07% |
XHLF | -7.97% | $1.46B | 0.03% |
VTIP | -7.52% | $14.78B | 0.03% |